Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Early opportunity to invest in a Nevada lithium project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Veru Inc.
VERU
Healthcare
Biotechnology
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic...
hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:VERU)
New Post
View:
Posts & Comments
Threaded Posts
(50)
•••
speedyg999
X
Post by
speedyg999
on Jul 11, 2022 5:55pm
Oppenheimer has US$36 Target for VERU
Up Up and Away. Poor Shorts. You almost have to feel sorry for them!
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Jul 08, 2022 8:02am
HERE’S A ROUND-UP ON VERU INC!
$VERU Veru, Inc. (NASDAQ: VERU) announced positive results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe
...more
(50)
•••
speedyg999
X
Post by
speedyg999
on Jul 06, 2022 6:14pm
SHORT SQUEEZE STARTING IN VERU
Watch this action, folks. There are a LOT of short sellers in this stock, and they are now losing their butts. if the FDA approves their Covid drug, this could double in short order. We should hear
...more
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:30am
VERU .....sold to America !!!!
Profit is almost $3.00 / share Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:26am
VERU ..... Yeehaaaaaaaaa !!!!!
I f'ing told ya ........ What's it at now !!!!!! Halted again..... It could triple from $17....hang in there Baby !!! Cheers to me !!!!!!!!!!!!!!!!!!!!!!!!!!
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:15am
VERU ..... $14.50 now ; )
$17 dolla holla Cheers !
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 10:02am
VERU ...resumed ....dipped ...now on up swing
This could explode higher.... JMHO $14 now
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2022 9:44am
VERU ....halted and on Watch list
Cheers !
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Aug 26, 2021 7:19am
3 BIOTECH STOCKS INSIDERS ARE SELLING
3 BIOTECH STOCKS INSIDERS ARE SELLING $VERU $FBIO $SGMO Learn More https://www.aviseanalytics.com/3-biotech-stocks-insiders-are-selling/
(24)
•••
TheMoneyMind
X
Post by
TheMoneyMind
on Dec 15, 2020 8:00am
VERU update
Still moving premarket tuesday! https://youtu.be/T8vPUhRoM2s
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Canada Nickel Continues to Intersect High-grade, Near-surface Mineralization at Texmont Project
DehydraTECH Licensing Revenues increases 5x and Hits Another Quarterly Record with New Licensees
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report